Form 4: Perspective Therapeutics Director Increases Stake with Recent Stock Purchases
SEC Form 4 Filing
Robert F. Williamson III, a director at Perspective Therapeutics, Inc., recently acquired additional shares of common stock through a series of transactions.
Summary
- On May 29, 2024, Robert F. Williamson III, a director of Perspective Therapeutics, Inc. (CATX), purchased shares of the company's common stock.
- The transactions involved the acquisition of 11,375 shares at $1.32 per share and 18,656 shares at $1.34 per share.
- Following these purchases, Williamson directly owns 368,792 shares of common stock.
- Additionally, he indirectly owns 3,663 shares through the RFW3 Revocable Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The director's purchase of shares may signal confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. Investors often monitor such filings for signals about management's confidence in the company.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive sign.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock purchase transactions |
| 05/30/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.